ROBERT J. BALCH
Since joining Cycad Group in 2004 Bob has been instrumental in founding and financing a number of companies across all investment areas and stages. Bob has served as a director or observer to the board of directors of a number of portfolio companies, including ClarVista Medical, Iosil Energy, Lixivia, Sofie, SteriFx, SpectraFluidics and Agile RF. Prior to joining Cycad Group, Bob was a founding partner of Taraval Associates Seed Capital Fund; a venture fund specializing early stage life sciences companies. As part of his activities with TASCF, Bob spent significant time working in Australia and New Zealand with entrepreneurs, government agencies and the venture capital communities (funding three companies and serving on the board of directors of one).
Bob brings extensive operations and management experience to his venture capital activities. Early in his career Bob worked in sales and marketing in the pharmaceutical and medical device industries. He was also among the earliest employees in two healthcare startups: EndoTherapeutics (minimally invasive surgery) and Tokos Medical (perinatal monitoring). Bob then spent 11 years with Mark Products, Inc., a telecommunications company. He was the General Manager of Mark Products, with responsibility for all aspects the business when he left to form Taraval Associates Seed Capital Fund in 1997.
Bob holds a B.Sc. in Biological Sciences from California State University, Sacramento, and an M.B.A. from the University of Phoenix.